microdosing glp 1 semaglutide GLP-1: Should You Try It? Benefits & Risks THE GLP-1 MICRODOSING PROGRAM

Eligible participants were adults who completed the Lifestyle Survey, had a documented or calculable body mass index, had at least one inpatient, outpatient, or emergency department visit in the past two years, and had no recorded history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or end-stage renal disease

The aim of their project was to determine the degree to which infusions of GLP-1 (7-36) stimulated the release of insulin compared with synthetic versions of GIP

Savings can be as high as 80%

Presented for research literature review only Vaidya V et al

Erratum in: Nutr Metab Cardiovasc Dis